BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Ultimate Trader

1 year 30%, 2 years 40% and *3 years 40%

*Across 3 years $3395.52 only $1697.76

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
6,032.38
0.56%
US Tech 100
20,389.60
0.00%
Dow Jones
44,910.65
0.42%
Brent Oil
72.245
0.24%
Bitcoin
95,985.05
-1.31%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Selvita Sa (0RKT) Quote

Selvita Sa

Selvita Sa (0RKT)

LSE
57.00
0.00
(0.00%)
Closed December 02 11:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
57.00
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
57.00 52 Week Range 57.00
Market Cap
1.318B
Previous Close
57.00
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
0.00
Shares Outstanding
23,120,000
Dividend Yield
-
PE Ratio
-14.31
Earnings Per Share (EPS)
-3.98
Revenue
67.99M
Net Profit
-92.11M

About Selvita Sa

Sector
Chemicals & Chem Preps, Nec
Industry
Chemicals & Chem Preps, Nec
Website
ryvu.com
Headquarters
Krakow, Pol
Founded
-
Selvita Sa is listed in the Chemicals & Chem Preps sector of the London Stock Exchange with ticker 0RKT. The last closing price for Selvita was PLN57. Over the last year, Selvita shares have traded in a share price range of PLN 57.00 to PLN 57.00.

Selvita currently has 23,120,000 shares outstanding. The market capitalization of Selvita is PLN1.32 billion. Selvita has a price to earnings ratio (PE ratio) of -14.31.

Ask ADVFN Intelligence (AI)

0RKT Latest News

More News

Ryvu Therapeutics presents clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium

Ryvu Therapeutics presents clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium PR Newswire KRAKOW, Poland, Oct. 23, 2024...

October 23 2024
PR Newswire (US)

Ryvu Therapeutics to present clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium

Ryvu Therapeutics to present clinical and preclinical data on RVU120, RVU305, and novel synthetic lethality programs at the 2024 EORTC-NCI-AACR Symposium PR Newswire KRAKOW, Poland, Oct. 9, 2024...

October 09 2024
PR Newswire (US)

Ryvu Therapeutics to present ONCO Prime platform at the 6th Annual RAS-Targeted Drug Development Summit

Ryvu Therapeutics to present ONCO Prime platform at the 6th Annual RAS-Targeted Drug Development Summit PR Newswire KRAKOW, Poland, Sept. 23, 2024 ONCO Prime is a cutting-edge drug discovery...

September 23 2024
PR Newswire (US)

Ryvu Therapeutics presents clinical and preclinical data on RVU120 at the 2024 European Hematology Association Congress

Ryvu Therapeutics presents clinical and preclinical data on RVU120 at the 2024 European Hematology Association Congress PR Newswire KRAKOW, Poland, June 14, 2024 RVU120 as a single agent showed...

June 14 2024
PR Newswire (US)

Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting

Ryvu Therapeutics to Present Preclinical Data on RVU120 and Synthetic Lethality Programs at the 2024 AACR Annual Meeting PR Newswire KRAKOW, Poland, March 6, 2024 Updated preclinical data will be...

March 06 2024
UK Regulatory

Ryvu Announces Dosing of the First Patient in the RIVER-52 Phase II Study of RVU120 as a Monotherapy for the Treatment of Patients with Relapsed/Refractory AML and HR-MDS

Ryvu Announces Dosing of the First Patient in the RIVER-52 Phase II Study of RVU120 as a Monotherapy for the Treatment of Patients with Relapsed/Refractory AML and HR-MDS PR Newswire KRAKOW...

February 14 2024
UK Regulatory

Ryvu Therapeutics to Present Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Meeting

Ryvu Therapeutics to Present Data on RVU120 at the 2023 American Society of Hematology (ASH) Annual Meeting PR Newswire KRAKOW, Poland, Nov. 2, 2023 Updated data from the Phase I trial of RVU120...

November 02 2023
PR Newswire (US)

Ryvu Therapeutics Reports 2022 Half-Year Financial Results and Provides Corporate Update

Ryvu Therapeutics Reports 2022 Half-Year Financial Results and Provides Corporate Update PR Newswire KRAKOW, Poland, Sept. 28, 2022 KRAKOW, Poland, Sept. 28, 2022 /PRNewswire/ -- Ryvu...

September 28 2022
PR Newswire (US)

Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association (EHA) Congress

Ryvu Therapeutics Presents Updated Clinical and Preclinical Data on RVU120 at the 2022 European Hematology Association (EHA) Congress PR Newswire KRAKOW, Poland, June 10, 2022 - Clinically...

June 10 2022
PR Newswire (US)

Ryvu Therapeutics to Present Data from its Oncology Programs at AACR 2022 Annual Meeting

Ryvu Therapeutics to Present Data from its Oncology Programs at AACR 2022 Annual Meeting PR Newswire KRAKOW, Poland, March 8, 2022 KRAKOW, Poland, March 8, 2022 /PRNewswire/ -- Ryvu Therapeutics...

March 08 2022
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10057575700DE
40057575700DE
120057575700DE
260057575700DE
520057575700DE
1560057575700DE
2600057575700DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0A2IH World Group Ltd
$ 0.00
(0.00%)
0
0A2DCrh Plc
$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
$ 72.15
(0.00%)
2.94k
0A2IH World Group Ltd
$ 0.00
(0.00%)
0
0A2DCrh Plc
$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
$ 72.15
(0.00%)
2.94k
ARBArgo Blockchain Plc
8.10p
(0.00%)
9.7M
0R0XTesla Inc
$ 339.20
(0.00%)
21.28k
0A6LGamestop Corp
$ 29.9025
(0.00%)
3.77k
0HCIAlibaba Group Holding Ltd
$ 86.90
(0.00%)
3.07k
0A1UUber Technologies Inc
$ 72.15
(0.00%)
2.94k

Discussion

View Full Feed
knrorrel knrorrel 11 minutes ago
Looks too $QSI - Quantum-Si Highlights Major Technical Advances, Next-Generation Platform Architecture and New Proteomic Applications at Investor & Analyst Event

November 21, 2024

Provides Update on the Company’s Innovation Roadmap & New Development Partnerships
QSI
knrorrel knrorrel 17 minutes ago
$QSI INCREASE COME https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175455634

QSI
boogeyman6757565 boogeyman6757565 19 minutes ago
https://community.geotab.com/s/question/0D5Pd00000Rz4SJKAZ/call-on-blockchain-support-number-need-helpline-number?language=en_US📲
QueenMinotaur95 QueenMinotaur95 19 minutes ago
https://community.geotab.com/s/question/0D5Pd00000Ryx2nKAB/contact-17076097626-how-do-i-contact-blockchain-support-number-easy-guide?language=en_US

https://community.geotab.com/s/question/0D5Pd00000RyxsLKAR/247-%F0%9D%95%83%F0%9D%95%9A%F0%9D%95%A7%F0%9D%95%96-support-how-do-i-contact-
Real McCoy Real McCoy 21 minutes ago
No one is interested in your shares. At all. They’re dead.
Real McCoy Real McCoy 21 minutes ago
Just trying to get to the end man.
Viking61 Viking61 24 minutes ago
Arnold has been saying the same all the way up from .40.
FNMA
knrorrel knrorrel 32 minutes ago
$QBTS the week is already starting nice and green in Germany. Let's see where it goes this week...... Quantum and ai the new shares of the future with enormous potential, imho
https://www.ariva.de/aktien/d-wave-quantum-systems-inc-aktie/kurse/handelsplaetze



QBTS
knrorrel knrorrel 32 minutes ago
$QBTS the week is already starting nice and green in Germany. Let's see where it goes this week...... Quantum and ai the new shares of the future with enormous potential, imho
https://www.ariva.de/aktien/d-wave-quantum-systems-inc-aktie/kurse/handelsplaetze

QBTS
AlwaysOptimistic AlwaysOptimistic 35 minutes ago
Great find GE. Hopefully, he can Make NioCorp Great Again!
NB
boogeyman6757565 boogeyman6757565 38 minutes ago
https://community.geotab.com/s/question/0D5Pd00000Rz3b0KAB/how-do-i-contact-blockchain-support-number-usa?language=en_US
https://community.geotab.com/s/question/0D5Pd00000Rz3b0KAB/how-do-i-contact-blockchain-support-number-usa?language=en_US
Krombacher Krombacher 38 minutes ago
SSC’s Endless Negativity: Let’s Address the Facts

1. Stock Performance
Yes, ERHC’s stock has declined over the years, but your constant harping on the historical decline ignores the nuance of long-term investment strategies. My positions have always been based on logical specul
ERHE
skeptical G skeptical G 41 minutes ago
was hoping for a Ravens win
IGPK
bbotcs bbotcs 46 minutes ago
Biden pardoned Hunter. Said he wouldn't, but we knew he would and he did. Who is going to pardon Joe?
bbotcs bbotcs 48 minutes ago
lj: SMCI
Bought shares at $35 and change last week. If the company survives, the purchase price will be a bargain in a year or so.
SMCI
Nrdc92 Nrdc92 48 minutes ago
That's how these cults work, Dan. The members are systematically groomed and then brainwashed, the result of which is to be unable to process facts outside the cult dogma. Here, it's even worse because the cult members have a financial stake in the cult, which provides additional incentive to remain
LWLG
nowwhat2 nowwhat2 50 minutes ago
Wooo-wooo !

https://investorshub.advfn.com/uimage/uploads/2024/12/2/evqdeLTC_111111_27_30d_chan.jpg




https://investorshub.advfn.com/uimage/uploads/2024/12/2/qrlzkltc_111111_30_30d_1pm_TL_W.jpg




https://investo
LTCUSD
Fdc4 Fdc4 1 hour ago
I would believe such from anything else but from HMBL. This is a ponzi mate, down it goes, no escape to nobody. Careful, CEO watching for more dilution space expansion
HMBL
Fdc4 Fdc4 1 hour ago
No FINRA or audit financials, I doubt this will see $0.006 again. Forget about $0.009, this is going down to trips
IGPK
Fdc4 Fdc4 1 hour ago
Now your are talking about your beliefs. Did you know your beliefs aren’t aligned with the real facts? If you want others to mind their business, keep your nonsense to yourself mate. Nobody want to hear a pumper that doesn’t have idea of what he is talking about. Chill kid
IGPK
Biotechotcguy Biotechotcguy 1 hour ago
Don't bet against the Jews. I'm in this till the end. 
DROR
sunspotter sunspotter 1 hour ago
Still howling at the moon, chazzy?

Time to admit that both HDVY and VPLM are both insider enrichment scams masquerading as wannabe patent trolls.
HDVY VPLM
Fdc4 Fdc4 1 hour ago
Good points Orca, well put
VDRM
BDEZ BDEZ 2 hours ago
No more income tax, Tariffs only. Do it

Your Recent History

LSE
0RKT
Selvita
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 50%* for Ultimate Trader

1 year 30%, 2 years 40% and *3 years 40%

*Across 3 years $3395.52 only $1697.76